|
DDX24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.35539998616474E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.93190000055787E-08 |
| Normal-vs-Stage2 |
1.30200000003633E-06 |
| Normal-vs-Stage3 |
1.200580E-03 |
| Normal-vs-Stage4 |
1.68180000004181E-06 |
| Stage1-vs-Stage2 |
4.910600E-01 |
| Stage1-vs-Stage3 |
3.925800E-01 |
| Stage1-vs-Stage4 |
2.123800E-01 |
| Stage2-vs-Stage3 |
2.832800E-01 |
| Stage2-vs-Stage4 |
5.034200E-01 |
| Stage3-vs-Stage4 |
1.590380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.5569999451136E-09 |
| Normal-vs-AfricanAmerican |
5.9859999956835E-08 |
| Normal-vs-Asian |
4.255200E-01 |
| Caucasian-vs-AfricanAmerican |
5.743200E-01 |
| Caucasian-vs-Asian |
4.631400E-01 |
| AfricanAmerican-vs-Asian |
5.317800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.0680014084794E-11 |
| Normal-vs-Female |
1.5654899999995E-05 |
| Male-vs-Female |
4.730100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.22230000010326E-07 |
| Normal-vs-Extreme_Weight |
4.1320999955019E-08 |
| Normal-vs-Obese |
3.3740999999532E-06 |
| Normal-vs-Extreme_Obese |
3.26500000003005E-06 |
| Normal_Weight-vs-Extreme_Weight |
5.988600E-01 |
| Normal_Weight-vs-Obese |
1.928580E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.019600E-01 |
| Extreme_Weight-vs-Obese |
2.909400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.743200E-01 |
| Obese-vs-Extreme_Obese |
1.417380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.768000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.29180000036011E-07 |
| Normal-vs-Age(61-80Yrs) |
8.61100080129518E-11 |
| Normal-vs-Age(81-100Yrs) |
6.37179999999349E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.943600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.304170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.563200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.062610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.587000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.262600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11959996829114E-09 |
| Normal-VS-Type2 PRCC |
3.34009999991558E-07 |
| Normal-VS-KIRP CIMP |
9.046000E-04 |
| Normal-VS-Unclassified PRCC |
2.45509999996507E-06 |
| Type1 PRCC-VS-Type2 PRCC |
9.869200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.856600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.445000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.974400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.646000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.815600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.83100000109116E-08 |
| Normal-vs-N1 |
1.793020E-04 |
| Normal-vs-N2 |
1.583510E-04 |
| N0-vs-N1 |
3.074600E-01 |
| N0-vs-N2 |
3.553400E-01 |
| N1-vs-N2 |
1.874440E-01 |
|
|
